Ativo Capital Management LLC - REATA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 57 filers reported holding REATA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Ativo Capital Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$1,133,000
+3.8%
50,0120.0%0.28%
+9.3%
Q4 2016$1,092,000
-23.3%
50,012
-7.4%
0.26%
-21.9%
Q3 2016$1,424,000
+59.5%
54,016
+19.5%
0.33%
+50.9%
Q2 2016$893,000–45,209–0.22%–
 Download
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$295,368,02659.26%
Ally Bridge Group (NY) LLC 105,558$10,762,69413.04%
First Light Asset Management, LLC 1,432,208$146,027,92811.44%
Boxer Capital, LLC 1,430,004$145,8036.76%
MPM BioImpact LLC 234,478$23,907,3774.81%
Tri Locum Partners LP 96,274$9,816,0973.65%
Altium Capital Management LP 41,485$4,229,8113.20%
Ghost Tree Capital, LLC 85,000$8,666,6002.86%
KRS Capital Management, LLC 27,941$2,848,8642.85%
Sofinnova Investments, Inc. 322,471$32,879,1432.15%
View complete list of REATA PHARMACEUTICALS INC shareholders